RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lawrence Albers to Fluvoxamine

This is a "connection" page, showing publications Lawrence Albers has written about Fluvoxamine.
Connection Strength

0.331
  1. Albers LJ, Ozdemir V, Marder SR, Raggi MA, Aravagiri M, Endrenyi L, Reist C. Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy. J Clin Psychopharmacol. 2005 Apr; 25(2):170-4.
    View in: PubMed
    Score: 0.260
  2. Saracino MA, Mercolini L, Flotta G, Albers LJ, Merli R, Raggi MA. Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Nov 07; 843(2):227-33.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support